Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

T Cell Exhaustion Marker (Flow-Directly Conjugated) Antibody Pack, Novus Biologicals™
SDP

Antibody Pack

Supplier:  Novus Biologicals NBP312863

Catalog No. NB176539


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

The Human T Cell Exhaustion Marker (Flow-Directly Conjugated) Antibody Sampler Pack contains antibodies to detect expression of inhibitory receptors associated with T cell exhaustion. T cells co-expressing these inhibitory receptors are found during chronic viral infection and within the TME of many solid tumors. Anti-PD-1 is directly conjugated to PE, while anti- CTLA-4, TIGIT, TIM-3, VISTA/B7-H5/PD-1H and LAG-3 are directly conjugated to APC. This pack contains 6 full sized vials of directly conjugated primary antibody. It will allow the user to determine the co-expression of emerging checkpoint targets like LAG-3, TIM-3, TIGIT, and VISTA with the established checkpoint target, PD-1 using flow cytometry. All antibodies have been validted for use in flow cytometry applications.
Specifications

Specifications

T Cell Exhaustion Marker (Flow-Directly Conjugated)
Monoclonal
See individual datasheets
See individual datasheets
RUO
Storage is content dependent.
Flow Cytometry
Unconjugated
Immune cell exhaustion markers, immune checkpoint markers, inhibitory receptors, T cell exhaustion markers
6 Vials
Human
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.